-
In this issue: FDA issues multiple drug safety alerts; ARBs and cancer risk; and FDA actions.
-
As of 2006, the ongoing transmission of indigenous wild poliovirus (WPV) was limited to only four countries Afghanistan, Pakistan, India, and Nigeria.
-
Herrera and colleagues reviewed the use of Interferon-ã release assays (IGRAs) for the diagnosis of latent tuberculosis infection (LTBI). Interferon-ã is released by CD4 cells when infected with Mycobacterium tuberculosis (MTB), and IGRAs measure Interferon-ã response in blood.
-
A 58-year-old liberian-born woman was in excellent general health, living and working in a large academic medical center in Rhode Island for more than 20 years when she developed nonspecific gastrointestinal symptoms and underwent endoscopy, which revealed Strongyloides stercoralis larvae on a duodenal biopsy in March 2010.
-
As of june 29, 2011, german authorities reported 3,189 cases of entero-hemorrhagic E. coli (EHEC) infections, and 884 other cases have also been identified.
-
Despite the recent gains achieved by multidisciplinary control programs, malaria still kills nearly 1 million people and causes almost 300 million symptomatic illnesses globally per year, with most of this burden borne by sub-Saharan Africa.
-
In this issue: Two new drugs for treatment of hepatitis C; NSAIDs and myocardial infarction risk; AIM-HIGH clinical trial stopped; and FDA actions.
-
Coccidioidal infections are always unique the travel history often provides the right clue for the practitioner but first you have to think to ask the right question.
-
Due to heightened surveillance of acute febrile illness in China, a severe illness associated with thrombocytopenia and multi-system organ involvement was recognized beginning in 2009.
-
Tropical Medicine Specialists Jan Clerinx and Alfons Van Gompel from Belgium provide a practical review of current knowledge about schistosomiasis as it relates to travelers and migrants, including good images of parasite lifestyle, maps, parasite eggs, and 223 references.